Israeli Study Links GLP-1 Drugs to Rare Brain Disorder

Study reveals possible link between GLP-1 weight loss drugs and rare brain condition

The Independent • 15 Սեպ 17:45

An Israeli review of FDA adverse-event reports identified 15 instances of Wernicke encephalopathy among users of GLP-1 medications, prompting calls for further investigation.

Ozempic and Wegovy may cause rare brain disorder, new study warns

Fox News • 13 Սեպ 17:00

A review of FDA reports and medical literature identified 15 cases of Wernicke encephalopathy among users of semaglutide and tirzepatide, prompting calls for further research.

Popular GLP-1 weight-loss drugs linked to potentially deadly brain disorder

Yahoo Health • 13 Սեպ 17:00

Researchers identified 15 reports of Wernicke encephalopathy in patients using GLP-1 receptor agonists, highlighting a possible link to vitamin B1 deficiency but noting the rarity of the condition.

GLP-1-driven vitamin deficiency linked to rare brain disorder: Study

NewsNation • 12 Սեպ 20:18

Researchers identified 15 cases of Wernicke encephalopathy in 2023-2024 among patients using GLP-1 agonists, highlighting a potential risk of severe thiamine deficiency.

2 popular GLP-1 drugs linked to rare, life-threatening brain disorder

New York Post • 11 Սեպ 16:09

Research involving nearly 196,000 patients identified 15 cases of Wernicke encephalopathy, a serious condition linked to vitamin B1 deficiency, that were disproportionately associated with semaglutide and tirzepatide.